Hogehilweg 18 Mon-Fri 08:30-17:30
MijnMedicijn
📞 Contact phone — free, 24/7
Medications

Motion Sickness

Medications and remedies for preventing and treating nausea, vomiting, dizziness and motion-related discomfort during car, sea or air travel. Includes antihistamine and anticholinergic antiemetics, patches, tablets, chewables, liquids, and nonpharmacologic aids like acupressure.

1
Products
1 products found
−10%
Dimenhydrinate
★★★★☆ 4.5 (40)
€0,76
€0,68
Buy Now

Motion Sickness

Medications and remedies for preventing and treating nausea, vomiting, dizziness and motion-related discomfort during car, sea or air travel. Includes antihistamine and anticholinergic antiemetics, patches, tablets, chewables, liquids, and nonpharmacologic aids like acupressure.

Motion sickness describes a range of uncomfortable sensations that occur when the brain receives conflicting signals about movement from the eyes, inner ears and body. Common symptoms include nausea, queasiness, sweating, dizziness and sometimes vomiting. Medications in this category are intended to prevent or reduce these symptoms by altering the body’s response to motion or by reducing the sensitivity of the balance system.

People use motion sickness medicines in a variety of everyday situations where travel or repetitive motion can trigger symptoms. Typical scenarios are car, bus, train, plane or boat trips, but similar medicines may also be suggested for vestibular disturbances related to inner ear conditions or for episodic vertigo. Some individuals use them occasionally for predictable travel, while others may need short courses for specific events or longer therapy under medical supervision for chronic balance disorders.

The products grouped under this category span several pharmacological classes. Antihistamine-type agents that have antiemetic and sedative effects are common; examples include meclizine and dimenhydrinate. Other compounds, such as cinnarizine, act on both histamine receptors and other pathways affecting vestibular function. Scopolamine, an anticholinergic available in some formulations, is another option used for its anti-nausea properties. These agents differ in how long they act, how likely they are to cause drowsiness, and their suitability for different age groups.

Formulations and patterns of use vary: tablets and chewables are commonly taken orally, while transdermal patches and suppositories are offered in some markets for people who cannot take oral medication. Some medicines are used preventively before exposure to motion, whereas others are taken after symptoms start; the choice often depends on the product’s onset of action and how long protection is needed. Over-the-counter availability differs by country and product, and some medicines are prescription-only depending on local regulations.

Safety considerations are an important part of selecting motion sickness medicines. Many of these agents can cause drowsiness, reduced alertness or dry mouth, and they may interact with alcohol, sedatives or other medications. Certain medical conditions—such as some heart or prostate problems, glaucoma, or significant respiratory issues—can affect which options are appropriate. Because risks and benefits vary by individual, people with chronic health issues, those taking multiple medicines, older adults and pregnant or breastfeeding individuals are commonly advised to discuss choices with a clinician or pharmacist.

When deciding which medicine to choose, consumers often weigh factors such as how quickly a product takes effect, how long relief lasts, potential for drowsiness, the ease of administration, and whether the product is suitable for children. Pack size, regulatory status (OTC versus prescription), and known interactions with other medications are also commonly considered. Reading the product information carefully and checking with a healthcare professional or pharmacist about suitability for specific personal circumstances helps users find the most appropriate option for managing motion-related symptoms.

Jeroen van den Berg
Medically reviewed by
Jeroen van den Berg
Registered Pharmacist (Apotheker), Chief Pharmacist and Head of Pharmacy Department